GLP Watchdog

LifeMD vs Push Health

Neither LifeMD nor Push Health has an FDA warning letter on record. Push Health publishes no GLP-1 price we could capture. LifeMD starts at $298 a month for brand-name semaglutide pill.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

LifeMD / Push Health

LifeMD logo

LifeMD

6.0/10

Push Health logo

Push Health

4.1/10

FDA warning letters
None on record
None on record
Pharmacy
Brand-name only; no compounding
None named in our record
Lowest standing price
$298/moBrand-name semaglutide pill
No GLP-1 price published
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026
Visit LifeMD
Visit Push Health

Neither LifeMD nor Push Health pays us. Links to them earn nothing. Scores: LifeMD 6.0, Push Health 4.1. How we are paid

What the record shows

  1. 01

    Neither LifeMD nor Push Health has an FDA warning letter on record.

  2. 02

    Push Health names no compounding pharmacy in our record. LifeMD sells brand-name medication only.

  3. 03

    Push Health publishes no GLP-1 price we could capture. LifeMD starts at $298 a month for brand-name semaglutide pill.

  4. 04

    Only LifeMD lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and brand-name semaglutide pill.

  5. 05

    LifeMD lists all 50 states. Push Health publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

LifeMD

Push Health

Brand-name semaglutide pen

$348/mo

$4,176 a year

Not sold or not priced
Brand-name tirzepatide pen

$448/mo

$5,376 a year

Not sold or not priced
Brand-name semaglutide pill

$298/mo

$3,576 a year

Not sold or not priced
Price includes
Clinician visits, labs, coaching
Not stated
Billed separately
Medication
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None
None
Refunds
Money-back guarantee after 12 months if under 10% loss and all conditions met
Full refund if you cancel before the provider writes a prescription; none after

Read off each seller’s own pages. LifeMD: October 31, 2026. Push Health: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for LifeMD

6.0/10
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Push Health does not price
  • Price leaves out medication
Visit LifeMD

The case for Push Health

4.1/10

The record gives Push Health no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no state list
  • Publishes no GLP-1 price
Visit Push Health

Scores

LifeMD 6.0 · Push Health 4.1 out of 10. Six weighted parts.

Value25%

3.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.5A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

LifeMD vs Push Health: questions

Neither LifeMD nor Push Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Push Health names no compounding pharmacy in our record. LifeMD sells brand-name medication only.
LifeMD states you can cancel at any time; refunds: money-back guarantee after 12 months if under 10% loss and all conditions met. Push Health states you can cancel at any time; refunds: full refund if you cancel before the provider writes a prescription; none after.
Neither LifeMD nor Push Health pays us. Links to them earn nothing. Scores: LifeMD 6.0, Push Health 4.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks